Filter
422
Filtered Results: 422
Text search:
pharmacokinetics
Featured
Recommendations
54
New Publications
87
Language
Document type
No document type
229
Guidelines
92
Studies & Reports
60
Manuals
17
Training Material
8
Fact sheets
7
Strategic & Response Plan
6
Situation Updates
2
Online Courses
1
Countries / Regions
India
24
Ethiopia
11
Global
11
Kenya
8
South Africa
7
Russia
7
Latin America and the Carribbean
6
Western and Central Europe
6
Africa
6
Sierra Leone
5
Uganda
5
Zimbabwe
5
Germany
5
Zambia
5
Bangladesh
5
Ghana
4
Namibia
4
Brazil
4
Eastern Europe
4
Liberia
3
Nigeria
3
Tanzania
3
Rwanda
3
Argentina
3
Ukraine
3
East and Southern Africa
3
South–East Asia Region
3
Cameroon
2
Cambodia
2
Thailand
2
Eswatini/ Swaziland
2
West and Central Africa
2
Paraguay
2
Burkina Faso
1
Congo, Democratic Republic of
1
Philippines
1
Nepal
1
South Sudan
1
Syria
1
Indonesia
1
Mozambique
1
Sudan
1
Botswana
1
Angola
1
Lesotho
1
Middle East and North Africa
1
Southern Africa
1
Australia
1
North America
1
Denmark
1
Authors & Publishers
Publication Years
Category
Countries
118
Clinical Guidelines
101
Public Health
20
Women & Child Health
16
Capacity Building
4
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
TB
68
HIV
53
AMR
37
Pharmacy
26
Mental Health
25
COVID-19
17
NTDs
17
Ebola
11
NCDs
10
Refugee
6
Planetary Health
6
Rapid Response
5
Caregiver
4
Disability
3
Polio
2
Global Health Education
2
Conflict
1
Natural Hazards
1
This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Food, private veterinary practitioners and swine produ...
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
These Guidelines on prudent use of antimicrobials in human health are based on a technical report prepared by the European Centre for Disease Prevention and Control (ECDC) with input from EU Member States experts and stakeholders, which should be referred to for details of the methodology used in cr...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Au Burkina Faso, les personnes vivant avec le VIH (PvVIH) ont régulièrement recours à des substances naturelles pour traiter certaines infections opportunistes. C’est ainsi que le suc des feuilles fraîches de Mitracarpus scaber Zucc. ex Schult. & Schult. f. (Rubiaceae) et de Senna alata (L.) R...
The animal health subsector within the agriculture sector is the gatekeeper of antimicrobial resistance (AMR) in livestock, aquaculture, animal products, and the immediate animal environment. In support of member countries taking responsibility for and moving forward with putting AMR monitoring and ...
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ...
Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand
Overuse of antimicrobial agents occurs globally in both community and hospital settings. Misuse of antibiotics can lead to a variety of adverse outcomes, including the development of antimicrobial resistanceand increased cost of hospitalization. This issuehas been particularly problematic in de...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Рекомендации, представленные в документе, в значительной степени
базируются на материалах по диагностике, профилактике и лечению COVID19, опубликованных специалист...
10 December 2020
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
N Engl J Med 2019;380:2429-39.DOI: 10.1056/NEJMoa1901113
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio...
doi: https://doi.org/10.1101/2020.11.30.20236570
Pre-Print Article
The manual has been designed in a comprehensive manner, the aim being to provide a holistic approach to the short-term development of human resources, with a focus on primary care physicians. This is a reference manual meant for primary care physicians who will provide care to older people in primar...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
